Ramifications of HLA class I polymorphism and population genetics for vaccine development

Genetic Epidemiology

Volumn 20, Issue 1, 2001, Pages 87-106

  Holmans, Peter ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

Author keywords

HLA restriction; HLA A; HLA B; Immune response; Synthetic peptide vaccine

Indexed keywords

CD8 ANTIGEN; EPITOPE; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; SYNTHETIC PEPTIDE; VACCINE;

ANTIGEN RECOGNITION; ARTICLE; ASIAN; CAUCASIAN; DNA POLYMORPHISM; ETHNOLOGY; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; NEGRO; PHENOTYPE; POPULATION GENETICS; VACCINE PRODUCTION;

ALGORITHMS; ALLELES; CONTINENTAL POPULATION GROUPS; DRUG DESIGN; EPITOPES; FLUORESCENT ANTIBODY TECHNIQUE; GENE FREQUENCY; GENES, MHC CLASS I; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; PHENOTYPE; POLYMORPHISM, GENETIC; PROTEIN BINDING; VACCINES, SYNTHETIC;

EID: 0035190275     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2272(200101)20:1<87::AID-GEPI8>3.0.CO;2-R     Document Type: Article

References (47)

1. Molecular analysis of presentation by HLA-2.1 of a promiscuously binding V3 loop peptide from the HIV-1 envelope protein to human cytotoxic T lymphocytes
2. The minimum peptide epitope from the influenza virus matrix protein
3. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis
4. Nomenclature for factors of the HLA system, 1994
5. Nomenclature for factors of the HLA system, 1998
6. The HL-A system in Bushman (San) and Hottentot (Khoikoi) populations of South West Africa
7. Systemic identification of optimal HIV-1 CTL epitopes
8. Novel HLA-Cw8-restricted T-cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens
9. HLA polymorphism of the principal minority nationalities in mainland China
10. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype
11. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL
12. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles
13. Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium boris BCG-vectored HIV vaccines
14. Herd immunity: History, theory, practice
15. Multiple HLA-A alleles can present an immunodominant peptide of the human melanoma antigen Melan-A/MART-1 to a peptide-specific HLA-A* 0201+cytotoxic T cell line
16. Herd immunity: Basic concept and relevance to public health immunization practices
17. HLA in South African populations
18. Priming of anti-human immunodeficiency virus (HIV) CD8+ cytotoxic T cells in vivo by carrier-free HIV synthetic peptides
19. Molecular analysis of the association of HLA-B53 and resistance to severe malaria
20. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups
21. AHS 2: HLA-A2, A28, A9, A203, A210
22. Correlating sequence variation with HLA-A allelic families: Implications for T cell receptor binding specificities
23. The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2
24. New treatment options for patients with melanoma: Review of melanoma-derived T-cell epitope-based peptide vaccines
25. HLA class I region sequences, 1998
26. Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA
27. Presence of HLA-C-restricted cytotoxic T-lymphocyte responses in long-term nonprogressors infected with human immunodeficiency virus
28. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing
29. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation
30. Mechanisms of MHC class I-restricted antigen processing
31. HLA ethnic study of Japanese and Koreans
32. HLA-B27 restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading
33. Allele assignment for HLA-A, -B, and -C genes to the Tenth International Histocompatibility Workshop cell lines
34. MHC ligands and peptide motifs: First listing
35. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides
36. A new era for cancer immunotherapy based on the genes that encode cancer antigens
37. Minimal phenotype panels: A method for achieving maximum population coverage with a minimum of HLA antigens
38. Several HLA alleles share overlapping peptide specificities
39. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide repertoires of common HLA molecules
40. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules
41. Two Listeria monocytogenes CTL epitopes are processed from the same antigen with different efficiencies
42. Molecular structure of human histocompatibility antigens: The HLA-C series
43. The a1/a2 domains of class I HLA molecules confer resistance to natural killing
44. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily. Implications for vaccine development
45. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability
46. Flow cytometric determination of peptide-class I complex formation